In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis like a Schedule III drug. This rescheduling will understand that cannabis has reputable professional medical applications and might help open up the door to study on other potential therapy takes advantage of. The amount of THC https://thca-guide12222.blazingblog.com/35235051/not-known-details-about-psychoactive-cannabinoids